Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Case report

Disseminated cryptococcosis in Crohn’s disease: a case report

Authors: Natthakit Chavapradit, Nasikarn Angkasekwinai

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Gastrointestinal (GI) cryptococcosis is rarely reported. Most cases were diagnosed during evaluation of comorbid conditions, incidental findings, or postmortem. Here, we present a case of Crohn’s disease with gastrointestinal cryptococcosis that resembled exacerbation of Crohn’s disease.

Case presentation

A 64-year-old woman with Crohn’s disease (CD) was referred to Siriraj Hospital due to worsening of abdominal pain and watery diarrhea for 2 weeks. The dose of immunosuppressive agents was increased for presumed exacerbation of CD. Pathologic examination of tissue obtained from polypoid mass at ileocecal valve and multiple clean-based ulcers at cecum revealed active ileitis and colitis with multiple round shape organisms with capsule, which was compatible with Cryptococcus species. Disseminated cryptococcosis was diagnosed due to gastrointestinal involvement and presumed pulmonary involvement regarding the presence of an oval-shaped cavitary lesion on chest X-ray and computed tomography of the lung. Patient was successfully treated with amphotericin B followed by fluconazole with satisfactory result.

Conclusion

Early diagnosis of gastrointestinal cryptococcosis in Crohn’s disease is difficult due to the lack of specific symptoms and sign or mimicking an exacerbation of Crohn’s disease. Seeking for other site of involvement in disseminated cryptococcosis including lung or central nervous system as well as detection of serum cryptococcal antigen would be helpful for early diagnosis and management.
Literature
1.
go back to reference Bratton EW, El Husseini N, Chastain CA, et al. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One. 2012;7:e43582.CrossRefPubMedPubMedCentral Bratton EW, El Husseini N, Chastain CA, et al. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One. 2012;7:e43582.CrossRefPubMedPubMedCentral
2.
go back to reference Wang LR, Barber CE, Johnson AS, Barnabe C. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum. 2014;44:325–30.CrossRefPubMed Wang LR, Barber CE, Johnson AS, Barnabe C. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum. 2014;44:325–30.CrossRefPubMed
3.
go back to reference George IA, Spec A, Powderly WG, Santos CAQ. Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), non-HIV non-transplant, and solid organ transplant associated Cryptococcosis: a population-based study. Clin Infect Dis. 2018;66:608–11.CrossRefPubMed George IA, Spec A, Powderly WG, Santos CAQ. Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), non-HIV non-transplant, and solid organ transplant associated Cryptococcosis: a population-based study. Clin Infect Dis. 2018;66:608–11.CrossRefPubMed
4.
go back to reference Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jpn J Infect Dis. 2008;61:111–5.PubMed Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jpn J Infect Dis. 2008;61:111–5.PubMed
5.
go back to reference Washington K, Gottfried MR, Wilson ML. Gastrointestinal cryptococcosis. Mod Pathol. 1991;4:707–11.PubMed Washington K, Gottfried MR, Wilson ML. Gastrointestinal cryptococcosis. Mod Pathol. 1991;4:707–11.PubMed
6.
go back to reference Osawa R, Singh N. Colitis as a manifestation of infliximab-associated disseminated cryptococcosis. Int J Infect Dis. 2010;14:e436–40.CrossRefPubMed Osawa R, Singh N. Colitis as a manifestation of infliximab-associated disseminated cryptococcosis. Int J Infect Dis. 2010;14:e436–40.CrossRefPubMed
7.
go back to reference Bonovas S, Fiorino G, Allocca M, et al. Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis. Clin Gastroenterol Hepatol. 2016;14:1385–97 e10.CrossRefPubMed Bonovas S, Fiorino G, Allocca M, et al. Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis. Clin Gastroenterol Hepatol. 2016;14:1385–97 e10.CrossRefPubMed
8.
go back to reference Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929–36.CrossRefPubMed Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929–36.CrossRefPubMed
9.
go back to reference Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8:443–68.CrossRefPubMed Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8:443–68.CrossRefPubMed
10.
go back to reference Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012;107:1409–22.CrossRefPubMedPubMedCentral Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012;107:1409–22.CrossRefPubMedPubMedCentral
11.
go back to reference Stamatiades GA, Ioannou P, Petrikkos G, Tsioutis C. Fungal infections in patients with inflammatory bowel disease: a systematic review. Mycoses. 2018;61:366–76.CrossRefPubMedPubMedCentral Stamatiades GA, Ioannou P, Petrikkos G, Tsioutis C. Fungal infections in patients with inflammatory bowel disease: a systematic review. Mycoses. 2018;61:366–76.CrossRefPubMedPubMedCentral
12.
go back to reference Takazono T, Izumikawa K, Yoshioka S, et al. Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review. Jpn J Infect Dis. 2012;65:461–4.CrossRefPubMed Takazono T, Izumikawa K, Yoshioka S, et al. Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review. Jpn J Infect Dis. 2012;65:461–4.CrossRefPubMed
13.
go back to reference Fraison JB, Guilpain P, Schiffmann A, et al. Pulmonary cryptococcosis in a patient with Crohn's disease treated with prednisone, azathioprine and adalimumab: exposure to chicken manure as a source of contamination. J Crohns Colitis. 2013;7:e11–4.CrossRefPubMed Fraison JB, Guilpain P, Schiffmann A, et al. Pulmonary cryptococcosis in a patient with Crohn's disease treated with prednisone, azathioprine and adalimumab: exposure to chicken manure as a source of contamination. J Crohns Colitis. 2013;7:e11–4.CrossRefPubMed
14.
go back to reference Takazono T, Sawai T, Tashiro M, et al. Relapsed pulmonary Cryptococcosis during tumor necrosis factor alpha inhibitor treatment. Intern Med. 2016;55:2877–80.CrossRefPubMedPubMedCentral Takazono T, Sawai T, Tashiro M, et al. Relapsed pulmonary Cryptococcosis during tumor necrosis factor alpha inhibitor treatment. Intern Med. 2016;55:2877–80.CrossRefPubMedPubMedCentral
15.
go back to reference Wysocki JD, Said SM, Papadakis KA. An uncommon cause of abdominal pain and fever in a patient with Crohn's disease. Gastroenterology. 2015;148:e12–3.CrossRefPubMed Wysocki JD, Said SM, Papadakis KA. An uncommon cause of abdominal pain and fever in a patient with Crohn's disease. Gastroenterology. 2015;148:e12–3.CrossRefPubMed
16.
go back to reference Sciaudone G, Pellino G, Guadagni I, Somma A, D'Armiento FP, Selvaggi F. Disseminated Cryptococcus neoformans infection and Crohn’s disease in an immunocompetent patient. J Crohns Colitis. 2011;5:60–3.CrossRefPubMed Sciaudone G, Pellino G, Guadagni I, Somma A, D'Armiento FP, Selvaggi F. Disseminated Cryptococcus neoformans infection and Crohn’s disease in an immunocompetent patient. J Crohns Colitis. 2011;5:60–3.CrossRefPubMed
17.
go back to reference Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:710–8.CrossRefPubMed Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:710–8.CrossRefPubMed
18.
go back to reference Yao ZW, Lu X, Shen C, Lin DF. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2014;33:1339–44.CrossRefPubMed Yao ZW, Lu X, Shen C, Lin DF. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2014;33:1339–44.CrossRefPubMed
Metadata
Title
Disseminated cryptococcosis in Crohn’s disease: a case report
Authors
Natthakit Chavapradit
Nasikarn Angkasekwinai
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3553-3

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue